» Articles » PMID: 12691662

Cdk5-mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-induced Apoptosis

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2003 Apr 15
PMID 12691662
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotoxic insults deregulate Cdk5 activity, which leads to neuronal apoptosis and may contribute to neurodegeneration. The biological activity of Cdk5 has been ascribed to its phosphorylation of cytoplasmic substrates. However, its roles in the nucleus remain unknown. Here we investigate the mechanism by which Cdk5 promotes neuronal apoptosis. We have identified the prosurvival transcription factor MEF2 as a direct nuclear target of Cdk5. Cdk5 phosphorylates MEF2 at a distinct serine in its transactivation domain to inhibit MEF2 activity. Neurotoxicity enhances nuclear Cdk5 activity, leading to Cdk5-dependent phosphorylation and inhibition of MEF2 function in neurons. MEF2 mutants resistant to Cdk5 phosphorylation restore MEF2 activity and protect primary neurons from Cdk5 and neurotoxin-induced apoptosis. Our studies reveal a nuclear pathway by which neurotoxin/Cdk5 induces neuronal apoptosis through inhibiting prosurvival nuclear machinery.

Citing Articles

Cyclin-dependent Kinase 5 and Neurodegenerative Diseases.

Song M, Qiang Y, Zhao X, Song F Mol Neurobiol. 2024; 61(10):7287-7302.

PMID: 38378992 DOI: 10.1007/s12035-024-04047-1.


Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models.

Guo B, Zheng C, Cao J, Luo F, Li H, Hu S J Adv Res. 2023; 64:195-211.

PMID: 37989471 PMC: 11464467. DOI: 10.1016/j.jare.2023.11.021.


Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy.

Miller N, Xu Z, Quinlan K, Ji A, McGivern J, Feng Z Proc Natl Acad Sci U S A. 2023; 120(47):e2300308120.

PMID: 37976261 PMC: 10666147. DOI: 10.1073/pnas.2300308120.


Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.

Xia L, Nie T, Lu F, Huang L, Shi X, Ren D Autophagy. 2023; 20(3):505-524.

PMID: 37772772 PMC: 10936626. DOI: 10.1080/15548627.2023.2259735.


Cyclin-dependent kinases: Masters of the eukaryotic universe.

Pluta A, Studniarek C, Murphy S, Norbury C Wiley Interdiscip Rev RNA. 2023; :e1816.

PMID: 37718413 PMC: 10909489. DOI: 10.1002/wrna.1816.